We are live on ! Find out more
KYMR icon

Kymera Therapeutics

115 hedge funds and large institutions have $2.04B invested in Kymera Therapeutics in 2021 Q3 according to their latest regulatory filings, with 21 funds opening new positions, 63 increasing their positions, 22 reducing their positions, and 16 closing their positions.

New
Increased
Maintained
Reduced
Closed

2,285% more call options, than puts

Call options by funds: $13.1M | Put options by funds: $549K

186% more repeat investments, than reductions

Existing positions increased: 63 | Existing positions reduced: 22

58% more capital invested

Capital invested by funds: $1.29B → $2.04B (+$749M)

31% more first-time investments, than exits

New positions opened: 21 | Existing positions closed: 16

8.91% more ownership

Funds ownership: 58.95%67.86% (+8.9%)

5% more funds holding

Funds holding: 110115 (+5)

0% more funds holding in top 10

Funds holding in top 10: 44 (0)

Holders
115
Holders Change
+5
Holders Change %
+4.55%
% of All Funds
2.01%
Holding in Top 10
4
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.07%
New
21
Increased
63
Reduced
22
Closed
16
Calls
$13.1M
Puts
$549K
Net Calls
+$12.5M
Net Calls Change
+$5.12M
Name Holding Trade Value Shares
Change
Change in
Stake
AGM
126
Alpine Global Management
New York
-$298K -6,144 Closed
VF
127
Virtu Financial
New York
-$295K -6,085 Closed
GT
128
Glenmede Trust
Pennsylvania
-$242K -5,000 Closed
Lazard Asset Management
129
Lazard Asset Management
New York
-$73K -1,512 Closed
PCM
130
Pinz Capital Management
New York
-$19K -400 Closed
S
131
SignatureFD
Georgia
-$1K -16 Closed